Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 3 Schemes (4.27%)
Foreign Institutions
Held by 17 Foreign Institutions (8.64%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
335 Million
(Quarterly Results - Dec 2025)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 383 Million (Micro Cap)
7.00
NA
0.00%
1.95
-999,999.00%
0.80






